New hepatitis drug to cost more in middle income nations; activists cry foul
Pharma company’s strategy of different prices for different countries to affect quality treatment of 185 million people infected with …
Effective oral drug for Hepatitis C approved by European agencies
Various patent barriers hinder its availability and affordability, especially in countries with high burden of disease
Big pharma’s dirty tricks
Drug giants from GSK, Abbott and Pfizer to Bayer have been fined for serious malpractices. They should be under close watch in India
Largest hybrid renewable energy system to be set up in Jamaica
80 kiloWatt installation will generate more than 106,000 kiloWatt hours of energy every year